Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test breakthrough could spot severe diverticulitis early

NCT ID NCT07322926

Knowledge-focused Sponsor: Haydarpasa Numune Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 101 patients with acute diverticulitis to see if routine blood tests could tell apart mild and severe cases. Researchers compared lab results like white blood cell count and C-reactive protein between the two groups. The goal was to find simple markers that help doctors decide who needs more aggressive treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could help doctors quickly identify which diverticulitis patients need more urgent care using routine blood tests.
What could go wrong
This is a small, retrospective study that only looks back at past data. The results need to be confirmed in larger, more diverse groups before they can be used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

101 people

The number who actually took part.

Started

Sep 2023

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

101 patients who were admitted to the Haydarpaşa Numune Training and Research Hospital General Surgery Clinic with the diagnosis of first acute diverticulitis attack between the years 2018-2022 were chosen.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Admission to the Haydarpaşa Numune Training and Research Hospital General Surgery Clinic * First episode of acute diverticulitis * Diagnosis confirmed by contrast-enhanced abdominal computed tomography (CT) * Admission between 2018 and 2022 * Retrospective identification from the hospital registry system Exclusion Criteria: * Recurrent episodes of diverticulitis * History of prior colorectal surgery * Symptom duration longer than 7 days before admission * Inconsistent physical examination findings with laboratory or imaging results * Age under 18 years * Pathologically confirmed malignancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diverticulitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diverticulitis Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diverticulitis

Contacts and locations

Locations

  • Haydarpasa Numune Research and Training Hospital

    Istanbul, 34668, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.